Soor Capital Acquires The Chemours Company Global Headquarters in Wilmington's Historic DuPont Building

Soor Capital completes $84 million acquisition of 283,069 square foot office condominium, fully leased to The Chemours Company in Wilmington's historic DuPont Building. The strategic investment features 100% occupancy with long-term triple net lease and prime location within one mile of central business district.

WILMINGTON, Delaware – July 16, 2019 – Soor Capital completed the acquisition of The Chemours Company Global Headquarters for $84 million. The 283,069 square foot office condominium is located within the iconic DuPont Building in downtown Wilmington's central business district and serves as the global corporate headquarters for The Chemours Company.

Strategic Asset Acquisition

The acquired property represents a premium office condominium interest that is 100% leased to The Chemours Company on a triple net basis with no termination or contraction options. The Property features a newly executed 15-year lease term commencing in December 2018, providing investors with 14.5 years of remaining lease term and steady cash flows protected from escalations in operating costs.

The historic DuPont Building, designated as a National Historic Landmark, is Delaware's largest mixed-use building totaling 968,738 square feet. Constructed in phases from 1913 to 1970, the Building underwent a comprehensive $175 million transformation project by current owner Buccini/Pollin Group to retain Chemours as an anchor tenant and create a distinctive mixed-use environment.

Exceptional Tenant Profile

The Chemours Company (NYSE: CC), founded in 2015 and headquartered in Wilmington, is a global leader in titanium technologies, fluoroproducts and chemical solutions with over $6.6 billion in annual revenue. The company serves more than 3,000 customers worldwide across approximately 130 countries and employs 7,000 people globally.

"This acquisition represents a strategic investment with one of the world's most respected chemical companies," said a spokesperson for Soor Capital. "Chemours' long-term commitment to these properties, combined with their proximity to the company's global headquarters, creates an exceptional investment opportunity."

Investment Highlights

The investment offers compelling characteristics including:

  • 100% occupied by The Chemours Company on long-term triple net lease
  • Prime location within one mile of Wilmington's central business district
  • Mission-critical facilities housing Chemours' global executive team and corporate operations
  • World-class tenant with exceptional operational and financial strength
  • Stable cash flow profile with built-in rent escalations

Market Position

Located approximately 27 miles southwest of Philadelphia's Central Business District, the property benefits from excellent connectivity to major transportation corridors. The Building is situated within walking distance to the Amtrak station providing access to the entire northeast corridor from Boston to Washington DC, enhancing its strategic value for corporate headquarters operations.

Strategic Partnership

Soor Capital worked in partnership with Arch Street Capital Advisors, L.L.C., which served as property-level advisor for the transaction. Since 2003, Arch Street has advised on over $7.3 billion in transactions across multiple real estate sectors, bringing extensive experience in advising international investors on U.S. real estate strategies.

About Soor Capital

Soor Capital is a private equity real estate firm offering comprehensive investment services across the USA, UK, Europe, and GCC regions. The firm specializes in acquiring institutional-quality real estate assets with superior tenant profiles and prime market locations. Since its establishment in 2018, Soor has transacted over $230 million of private equity real estate investments.